Andere Sprachen Samsung Biologics Co.,Ltd.

Aktien

A207940

KR7207940008

A207940

Pharmazeutika

Schlusskurs Korea S.E. Andere Börsenplätze 13.02.2026			% 5 Tage	Veränd. 1. Jan.
1’710’000.00 ^KRW	-0.52%		+71.00%	+71.00%

13.02.	Südkoreanische Aktien verzeichnen beste Woche seit über fünf Jahren dank KI-Rallye	RE
13.02.	Südkoreanische Aktien vor größtem Wochenanstieg seit über fünf Jahren dank KI-Optimismus	RE

Andere Sprachen

13.02.	South Korean shares post best week in more than five years on AI rally
13.02.	S.Korean shares set for biggest weekly jump in over five years on AI optimism
12.02.	South Korean shares hit record as chipmakers track US peers
11.02.	South Korean shares end 1% higher as automakers jump
11.02.	South Korean shares rise for third day on autos boost
09.02.	South Korean shares rise more than 4% on US chip boost
06.02.	Samsung Biologics Leads Climate Transparency with Independent Validation of Product Carbon Footprint System
06.02.	South Korean shares snap 6-week rally on AI worries
06.02.	South Korean shares fall nearly 4%, set for biggest weekly drop in 15 months
05.02.	South Korean shares fall nearly 4% after tech selloff on Wall Street
05.02.	South Korean shares fall after tech selloff on Wall Street
04.02.	South Korean shares rise to record close; nuclear energy, raw material stocks jump
04.02.	South Korean shares rise as auto, battery makers offset chipmaker losses
03.02.	The Coalition for Epidemic Preparedness Innovations and Samsung Biologics Collaborate to Strengthen Outbreak-Ready Vaccine Production and Global Access
03.02.	Cepi and Samsung Biologics collaborate to strengthen outbreak-ready vaccine production and global access
03.02.	South Korean shares rebound nearly 5% after US tech stocks jump
02.02.	South Korean shares fall 2% as investors weigh Trump's Fed chair choice
30.01.	South Korean shares post best month in nearly 3 decades on chip rally
30.01.	Samsung Bioepis secures European launch for eye medication
30.01.	South Korean shares march ahead, set to end week at record high
29.01.	South Korean shares notch record close as Hyundai Motor jumps
23.01.	South Korean shares cut gains after hitting record high
22.01.	Samsung Biologics reports fourth quarter and fiscal year 2025 financial results
22.01.	Samsung Biologics Co.,Ltd. Provides Earnings Guidance for the Year 2026
21.01.	Bourse : Alstom, Atos et Netflix publient, du mouvement chez Kering

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen MarketScreener Artikel MarketScreener Analysen Trading-Ideen

Andere Sprachen Samsung Biologics Co.,Ltd.

Aktien

A207940

KR7207940008

A207940

Pharmazeutika

Andere Sprachen

Filter